Longitudinal measures of circulating leptin and ghrelin concentrations are associated with the growth of young Peruvian children but are not affected by zinc supplementation

What Was Tested

Researchers studied Ghrelin in this randomized controlled trial publication.

The researchers examined the effects of supplemental zinc on plasma leptin, ghrelin, and insulin concentrations among young children at risk of zinc deficiency and examined the relations between these hormones and physical growth.

Why It Was Studied

Leptin, ghrelin, and insulin are hormonal regulators of energy balance and, therefore, may be related to growth during infancy.

Zinc is essential for growth, and its growth effects may be mediated through these hormones.

Who Took Part

By PubMed's age tags, the people studied were infants, both men and women.

How the Study Was Run

The design is described as randomized, double-blind and placebo-controlled.

Because people in this Ghrelin study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.

As a double-blind Ghrelin study, the assignments were hidden from both participants and investigators until the end.

A placebo (an inactive look-alike) gave the Ghrelin group a baseline to be compared against.

Relations between hormones and anthropometric z scores, body composition, and growth rates were examined at baseline and 3 and 6 mo after the start of the intervention.

What Was Measured

PubMed files the paper under topics including Body Composition, Body Height, Child Development, Dietary Supplements, Energy Metabolism, Food, Fortified and Ghrelin.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Ghrelin.

The abstract goes on to report its results in about 5 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2007 (The American journal of clinical nutrition), a journal based in United States.

More context: the Ghrelin compound page, all human trials.